Scotiabank Updates Price Target for Welltower WELL Amid Positive Outlook Federal Reserve Rate Cut Hopes Dim as April Jobs Data Reinforces Inflation Focus Analyst Report on Walmart Inc Highlights Retail Industry Dynamics Amid Market Uncertainty Technical Analysis Suggests Bullish IntermediateTerm Outlook Andaman Offshore Exploration Reveals Hydrocarbon Potential Gas Find with 87 Methane Trump Signals Shift in US Trade Policy Vows End to Economic Surrender Tutor Perini Corporation TPC Q1 2026 Earnings Strong EPS Beat Amid Revenue Disappointment PLOW Q1 2026 Earnings Earnings Surge 161 Above Estimates as Profitability Surprises Versus Systems Inc VS Q4 2025 Earnings Narrowing Loss Amid Flat Revenue Disclosure Theriva Biologics TOVX Q1 2026 Earnings Slight EPS Beat Boosts Sentiment for ClinicalStage Biotech GYRE Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage NervGen Pharma Q3 2025 Earnings Narrowed Loss Meets Estimates But Stock Plunges 43 Everspin Technologies MRAM Rallies 379 Key Levels in Focus RCI Hospitality RICK Gains 174 Approaching Key Resistance at 2576 EPR Properties EPR Faces Modest Pressure as Stock Slips 069 Infosys Shares Decline Amid Market Pressures Support and Resistance Levels in Focus Aurora Mobile JG Slides 895 as Selling Pressure Mounts Near Support Amazon Expands AI Shopping Technology to Retailers Secures Kate Spade as Customer Upwork Q1 2026 Earnings EPS Surges Past Estimates as Freelance Platform Gains Traction Mondelez International MDLZ Holds Steady Near Support as Consumer Staples Sector Provides Stability Spring Valley Acquisition Corp III Warrants SVACW Rally 44 Testing Resistance Near 20 Bullish Ordinary Shares BLSH Dips 217 Potential Support Levels in Focus Surrozen Warrants SRZNW Plummet 16 to 002 Evaluating Potential Risks and Levels Bitfarms Ltd BITF Holds Steady at 198 Key Support and Resistance Levels in Focus authID Inc AUID Slips Lower Amidst Narrow Trading Range Key Support Level in Focus Gabelli Convertible and Income Securities Fund GCV Gains 154 as Support Holds Steady Scinai Immunotherapeutics SCNI Declines 725 Eyes Key Support at 043